El Saftawy, Enas A.
Amin, Noha M.
Hamed, Dina H.
Elkazazz, Aly
Adel, Sherihan
Funding for this research was provided by:
Authors of the papers (9000)
Article History
Received: 14 December 2018
Accepted: 26 March 2019
First Online: 30 March 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Permission to conduct this study and ethical approval was received from the Deanship of Higher Education and Scientific Researches, Faculty of Medicine, Cairo University. The present study was conducted only on stool and serum samples of the selected cases.
: Aims and procedures of the study were explained and parents of all participants assigned informed consent before being enrolled in the study. Patients suffered from cancers were not included. After sample collection, <i>Blastocystis</i> infected patients were offered the antiprotozoal drug “metronidazole” with the standard dose of 40 mg/kg body weight.